Download PDF
Semin Neurol 2003; 23(4): 435-442
DOI: 10.1055/s-2004-817727
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Treatment of Orthostatic Hypotension

Roy Freeman
  • Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
Further Information

Publication History

Publication Date:
15 April 2004 (online)

    Permissions and Reprints

ABSTRACT

Orthostatic hypotension is the most incapacitating symptom of autonomic failure. This disorder occurs with both central autonomic neurodegenerative disorders, such as multiple system atrophy and Parkinson's disease, and peripheral autonomic disorders, such as the autonomic peripheral neuropathies and pure autonomic failure. The hallmark of both central and peripheral causes of neurogenic orthostatic hypotension is the failure to release norepinephrine appropriately upon standing. Patient education is the cornerstone of management. There are several measures that can be implemented to improve orthostatic tolerance prior to pharmacological intervention. Plasma volume expansion is essential to improve orthostatic tolerance, and fluid and sodium chloride intake should be increased. Most patients can be treated successfully with volume expansion or fludrocortisone or both in combination with a sympathomimetic agent. Desmopressin acetate and erythropoietin are useful supplementary agents in patients with more refractory symptoms. There are rare patients who will require additional agents to treat their symptoms. A small group of patients remain refractory to all therapeutic modalities.

KEYWORDS

Orthostatic hypotension - postural hypotension - autonomic failure - autonomic nervous system - sympathetic nervous system

REFERENCES

  • 1 Borst C, Weiling W, van Brederode F M J. et al . Mechanisms of initial heart rate response to postural change.  Am J Physiol . 1982;  243 H676-H681
    PubMedSearch in Google Scholar
  • 2 Smit A A, Halliwill J R, Low P A, Wieling W. Pathophysiological basis of orthostatic hypotension in autonomic failure.  J Physiol . 1999;  519(Pt 1) 1-10
    CrossrefPubMedSearch in Google Scholar
  • 3 Position paper. Orthostatic hypotension, multiple system atrophy (the Shy Drager syndrome) and pure autonomic failure.  J Auton Nerv Syst . 1996;  58 123-124
    CrossrefPubMedSearch in Google Scholar
  • 4 Goldstein D S, Polinsky R J, Garty M. et al . Patterns of plasma levels of catechols in neurogenic orthostatic hypotension.  Ann Neurol . 1989;  26 558-563
    CrossrefPubMedSearch in Google Scholar
  • 5 Goldstein D S, Holmes C, Sharabi Y, Brentzel S, Eisenhofer G. Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension.  Neurology . 2003;  60 1327-1332
    CrossrefPubMedSearch in Google Scholar
  • 6 Omboni S, Smit A A, van Lieshout J J, Settels J J, Langewouters G J, Wieling W. Mechanisms underlying the impairment in orthostatic tolerance after nocturnal recumbency in patients with autonomic failure.  Clin Sci (Lond) . 2001;  101 609-618
    PubMedSearch in Google Scholar
  • 7 van Lieshout J J, ten Harkel D A, Wieling W. Physical manoeuvres for combating orthostatic dizziness in autonomic failure.  Lancet . 1992;  339 897-898
    CrossrefPubMedSearch in Google Scholar
  • 8 Wieling W, van Lieshout J J, van Leeuwen M A. Physical manoeuvres that reduce postural hypotension in autonomic failure.  Clin Auton Res . 1993;  3 57-65
    CrossrefPubMedSearch in Google Scholar
  • 9 Shannon J, Jordan J, Costa F, Robertson R M, Biaggioni I. The hypertension of autonomic failure and its treatment.  Hypertension . 1997;  30 1062-1067
    PubMedSearch in Google Scholar
  • 10 Shannon J R, Jordan J, Diedrich A. et al . Sympathetically mediated hypertension in autonomic failure.  Circulation . 2000;  101 2710-2715
    CrossrefPubMedSearch in Google Scholar
  • 11 MacLean A R, Allen B V. Orthostatic hypotension and orthostatic tachycardia. Treatment with the “head-up” bed.  JAMA . 1940;  115 2162-2167
    PubMedSearch in Google Scholar
  • 12 Jordan J, Shannon J R, Black B K. et al . The pressor response to water drinking in humans: a sympathetic reflex?.  Circulation . 2000;  101 504-509
    CrossrefPubMedSearch in Google Scholar
  • 13 Campbell I W, Ewing D J, Clarke B F. 9-Alpha-fluorohydrocortisone in the treatment of postural hypotension in diabetic autonomic neuropathy.  Diabetes . 1975;  24 381-384
    CrossrefPubMedSearch in Google Scholar
  • 14 Hickler R B, Thompson G R, Fox L M, Hamlin J T. Successful treatment of orthostatic hypotension with 9-alpha-fluorohydrocortisone.  N Engl J Med . 1959;  261 788-791
    PubMedSearch in Google Scholar
  • 15 Schatz I J, Miller M J, Frame B. Corticosteroids in the management of orthostatic hypotension.  Cardiology . 1976;  61(Suppl. 1) 280-289
    PubMedSearch in Google Scholar
  • 16 van Lieshout J J, ten Harkel D A, Wieling W. Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure.  Clin Auton Res . 2000;  10 35-42
    CrossrefPubMedSearch in Google Scholar
  • 17 Chobanian A V, Volicer L, Tifft C P, Gavras H, Liang C S, Faxon D. Mineralocorticoid-induced hypertension in patients with orthostatic hypotension.  N Engl J Med . 1979;  301 68-73
    CrossrefPubMedSearch in Google Scholar
  • 18 Low P A, Gilden J L, Freeman R, Sheng K N, McElligott M A. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, doubleblind multicenter study. Midodrine Study Group.  JAMA . 1997;  277 1046-1051
    CrossrefPubMedSearch in Google Scholar
  • 19 Kaufmann H, Brannan T, Krakoff L, Yahr M D, Mandeli J. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine).  Neurology . 1988;  38 951-956
    CrossrefPubMedSearch in Google Scholar
  • 20 Wright R A, Kaufmann H C, Perera R. et al . A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension.  Neurology . 1998;  51 120-124
    CrossrefPubMedSearch in Google Scholar
  • 21 Jordan J, Shannon J R, Biaggioni I, Norman R, Black B K, Robertson D. Contrasting actions of pressor agents in severe autonomic failure.  Am J Med . 1998;  105 116-124
    CrossrefPubMedSearch in Google Scholar
  • 22 Ghrist D G, Brown G E. Postural hypertension with syncope: its successful treatment with ephedrine.  Am J Med Sci . 1928;  175 336-349
    PubMedSearch in Google Scholar
  • 23 Davies B, Bannister R, Sever P. Pressor amines and monoamine-oxidase inhibitors for treatment of postural hypotension in autonomic failure. Limitations and hazards.  Lancet . 1978;  1 172-175
    PubMedSearch in Google Scholar
  • 24 Biaggioni I, Onrot J, Stewart C K, Robertson D. The potent pressor effect of phenylpropanolamine in patients with autonomic impairment.  JAMA . 1987;  258 236-239
    CrossrefPubMedSearch in Google Scholar
  • 25 Freeman R. Treatment of orthostatic hypotension: Midodrine and other pressor drugs. In: Robertson D, Low PA, Polinsky RJ, eds. Primer on the Autonomic Nervous System New York: Academic Press 1996: 326-332
    Search in Google Scholar
  • 26 Fouad-Tarazi F M, Okabe M, Goren H. Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension.  Am J Med . 1995;  99 604-610
    CrossrefPubMedSearch in Google Scholar
  • 27 Kernan W N, Viscoli C M, Brass L M. et al . Phenylpropanolamine and the risk of hemorrhagic stroke.  N Engl J Med . 2000;  343 1826-1832
    CrossrefPubMedSearch in Google Scholar
  • 28 Kaufmann H, Oribe E, Miller M, Knott P, Wiltshire-Clement M, Yahr M D. Hypotension-induced vasopressin release distinguishes between pure autonomic failure and multiple system atrophy with autonomic failure.  Neurology . 1992;  42 590-593
    CrossrefPubMedSearch in Google Scholar
  • 29 Ozawa T, Oyanagi K, Tanaka H. et al . Suprachiasmatic nucleus in a patient with multiple system atrophy with abnormal circadian rhythm of arginine-vasopressin secretion into plasma.  J Neurol Sci . 1998;  154 116-121
    CrossrefPubMedSearch in Google Scholar
  • 30 Mathias C J, Fosbraey P, da Costa F D, Thornley A, Bannister R. The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure.  Br Med J (Clin Res Ed) . 1986;  293 353-354
    PubMedSearch in Google Scholar
  • 31 Sakakibara R, Matsuda S, Uchiyama T, Yoshiyama M, Yamanishi T, Hattori T. The effect of intranasal desmopressin on nocturnal waking in urination in multiple system atrophy patients with nocturnal polyuria.  Clin Auton Res . 2003;  13 106-108
    CrossrefPubMedSearch in Google Scholar
  • 32 Biaggioni I, Robertson D, Krantz S, Jones M, Haile V. The anemia of primary autonomic failure and its reversal with recombinant erythropoietin.  Ann Intern Med . 1994;  121 181-186
    PubMedSearch in Google Scholar
  • 33 Winkler A S, Marsden J, Parton M, Watkins P J, Chaudhuri K R. Erythropoietin deficiency and anaemia in multiple system atrophy.  Mov Disord . 2001;  16 233-239
    CrossrefPubMedSearch in Google Scholar
  • 34 Winkler A S, Landau S, Watkins P, Chaudhuri K R. Observations on haematological and cardiovascular effects of erythropoietin treatment in multiple system atrophy with sympathetic failure.  Clin Auton Res . 2002;  12 203-206
    CrossrefPubMedSearch in Google Scholar
  • 35 Rao S V, Stamler J S. Erythropoietin, anemia, and orthostatic hypotension: the evidence mounts.  Clin Auton Res . 2002;  12 141-143
    CrossrefPubMedSearch in Google Scholar
  • 36 Hoeldtke R D, Streeten D HP, Streeten D H. Treatment of orthostatic hypotension with erythropoietin.  N Engl J Med . 1993;  329 611-615
    CrossrefPubMedSearch in Google Scholar
  • 37 Perera R, Isola L, Kaufmann H. Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure.  Clin Auton Res . 1995;  5 211-213
    CrossrefPubMedSearch in Google Scholar
  • 38 Onrot J, Goldberg M R, Biaggioni I, Hollister A S, Kingaid D, Robertson D. Hemodynamic and humoral effects of caffeine in autonomic failure. Therapeutic implications for postprandial hypotension.  N Engl J Med . 1985;  313 549-554
    PubMedSearch in Google Scholar
  • 39 Robertson D, Goldberg M R, Hollister A S, Wade D, Robertson R M. Clonidine raises blood pressure in idiopathic orthostatic hypotension.  Am J Med . 1983;  74 193-199
    CrossrefPubMedSearch in Google Scholar
  • 40 Robertson D, Goldberg M R, Tung C S, Hollister A S, Robertson R M. Use of alpha 2 adrenoreceptor agonists and antagonists in the functional assessment of the sympathetic nervous system.  J Clin Invest . 1986;  78 576-581
    PubMedSearch in Google Scholar
  • 41 Onrot J, Goldberg M R, Biaggioni I, Wiley R G, Hollister A S, Robertson D. Oral yohimbine in human autonomic failure.  Neurology . 1987;  37 215-220
    PubMedSearch in Google Scholar
  • 42 Mehlsen J, Trap-Jensen J. Xamoterol, a new selective beta-1-adrenoceptor partial agonist, in the treatment of postural hypotension.  Acta Med Scand . 1986;  219 173-177
    PubMedSearch in Google Scholar
  • 43 Obara A, Yamashita H, Onodera S, Yahara O, Honda H, Hasebe N. Effect of xamoterol in Shy-Drager syndrome.  Circulation . 1992;  85 606-611
    PubMedSearch in Google Scholar
  • 44 West J N, Stallard T J, Dimmitt S B, Smith S A, Williams A, Littler W A. Xamoterol in the treatment of orthostatic hypotension associated with multiple system atrophy (Shy-Drager syndrome).  Q J Med . 1990;  74 209-213
    PubMedSearch in Google Scholar
  • 45 Cleophas T J, Grabowsky I, Niemeyer M G, Makel W M, van der Wall E E. Paradoxical pressor effects of beta-blockers in standing elderly patients with mild hypertension: a beneficial side effect.  Circulation . 2002;  105 1669-1671
    CrossrefPubMedSearch in Google Scholar
  • 46 Chobanian A V, Volicer L, Liang C S, Kershaw G, Tifft C. Use of propranolol in the treatment of idiopathic orthostatic hypotension.  Trans Assoc Am Physicians . 1977;  90 324-334
    PubMedSearch in Google Scholar
  • 47 Man in't Veld J A, Schalekamp M A. Pindolol acts as beta-adrenoceptor agonist in orthostatic hypotension: therapeutic implications.  Br Med J (Clin Res Ed) . 1981;  282 929-931
    PubMedSearch in Google Scholar
  • 48 Leslie P J, Thompson C, Clarke B F, Ewing D J. A double-blind crossover study of oral xamoterol in postural hypotension due to diabetic autonomic neuropathy.  Clin Auton Res . 1991;  1 119-123
    CrossrefPubMedSearch in Google Scholar
  • 49 Hoeldtke R D, Israel B C. Treatment of orthostatic hypotension with octreotide.  J Clin Endocrinol Metab . 1989;  68 1051-1059
    PubMedSearch in Google Scholar
  • 50 Hoeldtke R D, Horvath G G, Bryner K D, Hobbs G R. Treatment of orthostatic hypotension with midodrine and octreotide.  J Clin Endocrinol Metab . 1998;  83 339-343
    CrossrefPubMedSearch in Google Scholar
  • 51 Freeman R, Landsberg L, Young J. The treatment of neurogenic orthostatic hypotension with 3,4-DL-threo- dihydroxyphenylserine: a randomized, placebo-controlled, crossover trial.  Neurology . 1999;  53 2151-2157
    CrossrefPubMedSearch in Google Scholar
  • 52 Mathias C J, Senard J M, Braune S. et al . L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure.  Clin Auton Res . 2001;  11 235-242
    CrossrefPubMedSearch in Google Scholar
  • 53 Kaufmann H, Saadia D, Voustianiouk A. et al . Norepinephrine precursor therapy in neurogenic orthostatic hypotension.  Circulation . 2003;  108 724-728
    CrossrefPubMedSearch in Google Scholar
  • 54 Freeman R, Young J B, Landsberg L, Lipsitz L A. The treatment of postprandial hypotension in autonomic failure with 3,4-DL-threo-dihydroxyphenylserine.  Neurology . 1996;  47 1414-1420
    PubMedSearch in Google Scholar
  • 55 Hoeldtke R D, Cavanaugh S T, Hughes J D, Polansky M. Treatment of orthostatic hypotension with dihydroergotamine and caffeine.  Ann Intern Med . 1986;  105 168-173
    PubMedSearch in Google Scholar
  • 56 Fouad F M, Tarazi R C, Bravo E L. Dihydroergotamine in idiopathic orthostatic hypotension: short- term intramuscular and long-term oral therapy.  Clin Pharmacol Ther . 1981;  30 782-789
    PubMedSearch in Google Scholar
  • 57 Jennings G, Esler M, Holmes R. Treatment of orthostatic hypotension with dihydroergotamine.  BMJ . 1979;  2 307
    PubMedSearch in Google Scholar
  • 58 Biaggioni I, Zygmunt D, Haile V, Robertson D. Pressor effect of inhaled ergotamine in orthostatic hypotension.  Am J Cardiol . 1990;  65 89-92
    CrossrefPubMedSearch in Google Scholar
  • 59 Watt S J, Tooke J E, Perkins C M, Lee M R. The treatment of idiopathic orthostatic hypotension: a combined fludrocortisone and flurbiprofen regime.  Q J Med . 1981;  50 205-212
    PubMedSearch in Google Scholar
  • 60 Kochar M S, Itskovitz H D. Treatment of idiopathic orthostatic hypotension (Shy-Drager syndrome) with indomethacin.  Lancet . 1978;  1 1011-1014
    PubMedSearch in Google Scholar
  • 61 Lopes de Faria R S, Zanella M T, Andriolo A, Ribeiro A B, Chacra A R. Peripheral dopaminergic blockade for the treatment of diabetic orthostatic hypotension.  Clin Pharmacol Ther . 1988;  44 670-674
    PubMedSearch in Google Scholar
  • 62 Magnifico F, Pierangeli G, Barletta G. et al . The cardiovascular effects of metoclopramide in multiple system atrophy and pure autonomic failure.  Clin Auton Res . 2001;  11 163-168
    PubMedSearch in Google Scholar
  • 63 Singer W, Opfer-Gehrking T L, McPhee B R, Hilz M J, Bharucha A E, Low P A. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension.  J Neurol Neurosurg Psychiatry . 2003;  74 1294-1298
    CrossrefPubMedSearch in Google Scholar